Immunic Therapeutics Developing Selective Oral Drugs in Immunology NASDAQ: IMUX Piper Jaffray 31st Annual Healthcare Conference December 5, 2019 Cautionary Note Regarding Forward-Looking Statements • Certain statements contained in this presentation regarding matters that are not historical facts are forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, known as the PSLRA. These include s ...